We're currently fundraising! Become an early investor in Bioverge to own an expanding portfolio of leading TechBio startups through a single investment 🔬! Learn more and invest today 💸!
Yieyxrsfsiycizcbnuds

Evolving Failures in an Evolving Pandemic and What Needs to Be Done

Dr. Eric Topol, founder and director of the Scripps Research Translational Institute, sits down with Neil to discuss the COVID-19 delta variant, our failures to evolve with the virus, and what steps need to be taken to combat the ongoing pandemic.

continue reading >
Wfajhg7jquawlzel0nf1

Democratizing Entrepreneurship

Soundcloud link: https://soundcloud.com/user-770548556/democratizing-entrepreneurship Juan Scarlett, managing director of OneValley Ventures, sits down with Neil to discuss OneValley's efforts to democratize entrepreneurship and his approach investing in pre-seed and seed funding rounds.

continue reading >
8nys0ffnsigxpq6obfzw

Bridging the Translational Science Divide

Soundcloud link: https://soundcloud.com/user-770548556/bridging-the-translational-science-divide Pete Schultz, CEO of Scripps Research, sits down with Neil to discuss his efforts to create a self-sustaining nonprofit drug discovery and development institute and it’s work to advance small molecule regenerative therapies from the lab to the clinic.

continue reading >
C1kwmrursjxxjs082znw

Healthcare-Focused Impact Investing: Another Way To Invest For Change

Healthcare provides another avenue in which investors can do well by doing good.

continue reading >
16jqvvtoc2djv2ggjliw

Enveda Investment Thesis

Bioverge recently invested in Enveda’s $51 million Series A led by Lux Capital.  Enveda is biotechnology startup focused on harnessing the power of nature’s chemistry to develop next generation small-molecule therapeutics.

continue reading >
Obols5votkmhh1nfaocj

Managed marketplaces and reality TV: How a new generation of gatekeepers is opening biotech up to amateur investors

Starton Therapeutics, a drug delivery biotech, is raising its next round of capital through Unicorn Hunters, a streaming show that invites viewers to consider and invest in a variety of startups alongside a panel of celebrity investors.

continue reading >
1g9vsocptzevfhfskitq

Why the FDA Was Right to Approve Biogen's Aduhelm

https://soundcloud.com/user-770548556/neil-sits-down-with-attorney-james-valentine-to-get-his-contrary-take-on-the-recent-controversal-fda-approval-of-biogens-alzheimers-drug-aduhelm James Valentine, an attorney with Hyman, Phelps & McNamara specializing in regulatory law, sits down with Neil to discuss the FDA’s accelerated approval of Biogen’s Aduhelm for Alzheimer’s disease and offers a contrarian take on the controversy.

continue reading >
C6jfl3hhtiohykcygh7t

Juno Diagnostics Investment

Juno Diagnostics, a San Diego based genetic diagnostics company in the Bioverge portfolio, just raised a $25 million Series A round led by Perceptive Xontogeny Venture Fund in May 2021.

continue reading >
Bkect61tqqoepbcvxb2j

Managing the Challenges of Scaling Cell and Gene Therapies

Soundcloud link: https://soundcloud.com/user-770548556/managing-the-challenges-of-scaling-cell-and-gene-therapies Amy DuRoss, co-founder and CEO of Vineti, sits down with Neil to discuss how the company’s platform technology addresses the unique supply chain management challenges of cell and gene therapy companies.

continue reading >
Yieyxrsfsiycizcbnuds
Media

Evolving Failures in an Evolving Pandemic and What Needs to Be Done

Dr. Eric Topol, founder and director of the Scripps Research Translational Institute, sits down with Neil to discuss the COVID-19 delta variant, our failures to evolve with the virus, and what steps need to be taken to combat the ongoing pandemic.

Continue Reading >
Wfajhg7jquawlzel0nf1
Media

Democratizing Entrepreneurship

Soundcloud link: https://soundcloud.com/user-770548556/democratizing-entrepreneurship Juan Scarlett, managing director of OneValley Ventures, sits down with Neil to discuss OneValley's efforts to democratize entrepreneurship and his approach investing in pre-seed and seed funding rounds.

Continue Reading >
8nys0ffnsigxpq6obfzw
Media

Bridging the Translational Science Divide

Soundcloud link: https://soundcloud.com/user-770548556/bridging-the-translational-science-divide Pete Schultz, CEO of Scripps Research, sits down with Neil to discuss his efforts to create a self-sustaining nonprofit drug discovery and development institute and it’s work to advance small molecule regenerative therapies from the lab to the clinic.

Continue Reading >
C1kwmrursjxxjs082znw
Investing

Healthcare-Focused Impact Investing: Another Way To Invest For Change

Healthcare provides another avenue in which investors can do well by doing good.

Continue Reading >
16jqvvtoc2djv2ggjliw
Investing

Enveda Investment Thesis

Bioverge recently invested in Enveda’s $51 million Series A led by Lux Capital.  Enveda is biotechnology startup focused on harnessing the power of nature’s chemistry to develop next generation small-molecule therapeutics.

Continue Reading >
Obols5votkmhh1nfaocj
Press

Managed marketplaces and reality TV: How a new generation of gatekeepers is opening biotech up to amateur investors

Starton Therapeutics, a drug delivery biotech, is raising its next round of capital through Unicorn Hunters, a streaming show that invites viewers to consider and invest in a variety of startups alongside a panel of celebrity investors.

Continue Reading >
1g9vsocptzevfhfskitq
Media

Why the FDA Was Right to Approve Biogen's Aduhelm

https://soundcloud.com/user-770548556/neil-sits-down-with-attorney-james-valentine-to-get-his-contrary-take-on-the-recent-controversal-fda-approval-of-biogens-alzheimers-drug-aduhelm James Valentine, an attorney with Hyman, Phelps & McNamara specializing in regulatory law, sits down with Neil to discuss the FDA’s accelerated approval of Biogen’s Aduhelm for Alzheimer’s disease and offers a contrarian take on the controversy.

Continue Reading >
C6jfl3hhtiohykcygh7t
Startups

Juno Diagnostics Investment

Juno Diagnostics, a San Diego based genetic diagnostics company in the Bioverge portfolio, just raised a $25 million Series A round led by Perceptive Xontogeny Venture Fund in May 2021.

Continue Reading >
Bkect61tqqoepbcvxb2j
Media

Managing the Challenges of Scaling Cell and Gene Therapies

Soundcloud link: https://soundcloud.com/user-770548556/managing-the-challenges-of-scaling-cell-and-gene-therapies Amy DuRoss, co-founder and CEO of Vineti, sits down with Neil to discuss how the company’s platform technology addresses the unique supply chain management challenges of cell and gene therapy companies.

Continue Reading >
Next